Restless legs syndrome;Rastloøse bein

Tidsskrift for den Norske Laegeforening

Volumn 124, Issue 1, 2004, Pages 25-27

  Kinge, Einar ^a   Lossius, Morten Ingvar ^b  

^a Sandvika Nevrologpraksis   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CABERGOLINE; CLONAZEPAM; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NITRAZEPAM; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; TRIAZOLAM;

CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DOPAMINERGIC SYSTEM; DYSESTHESIA; HUMAN; IRON DEFICIENCY; LIMB MOVEMENT; META ANALYSIS; MOTOR ACTIVITY; PARESTHESIA; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; REST; RESTLESS LEGS SYNDROME; REVIEW; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNDROME DELINEATION;

DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGENTS; DOPAMINE AGONISTS; HUMANS; LEVODOPA; RESTLESS LEGS SYNDROME;

EID: 1342333609     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Odin P, Mrowka M, Shing S. Restless legs syndrome. Eur Neurol 2002; 9 (suppl 3): 59-67.
2. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994; 17: 739-43.
3. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population. The MEMO study. Neurology 2000; 54: 1064-8.
4. Ulfberg J, Nyström B, Carter N, Edling C. Restless legs syndrome among working-aged women. Eur Neurol 2001; 46: 17-9.
5. Ulfberg J, Nyström B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic diseases and neuropsychiatric symptoms. Mov Disord 2001; 16: 1159-63.
6. Philips B, Young T, Laurel F, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptom in adults. Arch Intern Med 2000; 160: 2137-41.
7. Walters AS, Hickey K, Maltzman J, Verrico T, Hening JW, Wilson V et al. A questionnaire study of 138 patients with restless legs syndrome: the «night walkers» survey. Neurology 1996; 46: 92-5.
8. Milligan SA, Chesson A. Restless legs syndrome in the older adult. Diagnosis and management. Drugs Aging 2002; 19: 741-51.
9. Hening W, Allen R, Early C, Kushida C, Pichietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999; 22: 970-99.
10. Ondo W, Jankovic J. Restless legs syndrome. Clinoetiologic correlates. Neurology 1996; 47: 1435-41.
11. Polydefkis M, Allen RP, Hauer P, Earley CJ, Griffin JW, McArthur JC. Subclinical sensory neuropathy in late - onset restless legs syndrome. Neurology 2000; 55: 1115-21.
12. Allen RP, Earley CJ. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 2000; 1: 11-9.
13. Ondo WG, Vyong KD, Wang Q. Restless legs syndrome in monozygote twins: clinical correlates. Neurology 2000; 55: 1404-6.
14. Lazzarini A, Walters AS, Hickey K, Goccagna G, Lugaresi E, Eherenberg BL. Studies of penetrance and antipation in five autosomal-dominant restless legs syndrome pedigrees. Mov Disord 1999; 14: 111-6.
15. Desautels A, Turecki G, Montplaisir J, Sequeria A, Verner A, Roleau GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001; 69: 1266-70.
16. Turjanski N, Lees AJ, Brooks DJ, Striatal dopaminergic function in restless legs syndrome. 18F-dopa and 11C raclopride PET studies. Neurology 1999; 52: 932-7.
17. Montplaisir J, Denesle R, Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol 2000; 7 (suppl 1): 27-31.
18. Collado-Seidel V, Kazenwadel J, Wetter TC, Kohnen R, Winkelmann J, Selzer R et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology 1999; 52: 285-90.
19. von Scheele C, Kempi V. Long-term effect of dopaminergic drugs in restless legs. A 2-year follow up. Arch Neurol 1990; 47: 1223-4.
20. Becker PM, Jamieson AO, Brown WD. Dopaminergic agents in restless legs syndrome and periodic leg movements in sleep: response and complications of extended treatment in 49 cases. Sleep 1993; 16: 713-6.
21. Allen RP, Early CJ. Augmentation of the restless legs syndrom with carbidopa/levodopa. Sleep 1996; 19: 205-13.
22. Walters AS, Hening WA, Kavey N, Chokroverty S, Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1996; 24: 445-58.
23. Wetter TC, Stiansy K, Winkelmann J, Buhlinger A, Brandenburg U, Penzel T et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 52: 944-50.
24. Stiansy K, Moller JC, Oertel WH. Safety of pramipexole in patients with restless legs syndrome. Neurology 2000; 55: 1589-90.
25. Stiansy K, Robbecke J, Schuler P, Pertel WH. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline - an open clinical trial. Sleep 1999; 23: 348-54.
26. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilaa B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999: 52: 938-43.
27. Ondo W. Ropinirol for restless legs syndrome. Mov Disord 1999; 14: 138-40.
28. Ahmed I. Ropinirol in restless leg syndrome. Mo Med 2002; 99: 500-1.
29. Saletu B, Gruber G, Saletu M, Brandstätter N, Hauer C, Prause W et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirol. 1. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology 2000; 41: 181-9.
30. Saletu M, Anderer P, Saletu B, Hauer C, Mandl M, Obendorfer S et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effect of ropinirol. 2. Findings on periodic leg movements, arousal and respiratory variables. Neuropsychobiology 2000; 41: 190-9.
31. Staedt J, Stoppe G, Kögler A, Munz D, Riemann H, Emrich D et al. Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm Gen Sect 1993; 93: 71.
32. Eisensehr I, Wetter TC, Linke R, Noachter S, Lindeiner Hv, Gildenhaus FJ et al. Normal IPT and IBZ SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2001; 57: 1307-9.
33. Ruottinen HN, Partinen M, Hublin C, Bergman J, Haaparanta M, Solin O et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000; 54: 502-4.
34. Trenkwalder C, Walters AS, Hening WA, Chokroverty S, Antonini A, Dhawan V et al. Positron emission tomographic studies in restless legs syndrome. Mov Disord 1999; 14: 141-5.
35. Walters AS, Winkelmann J, Trenkwalder C, Fry JM, Kataria V, Wagner M et al. Long-term follow up on restless legs syndrome patients treated with opioids. Mov Disord 2001; 16: 1105-9.
36. Hening WA. Restless legs syndrome: a sensimotor disorder of sleep/wake motor regulation. Curr Neurol Neurosci Rep 2002; 2: 186-96.
37. Earley CJ, Allen RP, Beard JL, Connor JR. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 2000; 62: 623-8.
38. Walters AS. Toward a better definition of the restless legs syndrome. Mov Disord 1995; 10: 634-42.
39. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J et al. Restless legs syndrome: diagnostic criteria, special consideration, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-19.
40. Chesson AL, Wise M, Davila D, Johnson S, Littner M, Anderson WM et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999; 22: 961-8.
41. Comella CL. Restless legs syndrome. Treatment with dopaminergic agents. Neurology 2002; 58 (suppl 1): S878-S89.
42. Telstad W, Sorenson O, Larsen S, Lillevold PE, Stensrud P, Nyberg-Hansen R. Treatment of restless legs syndrome with carbamazepine: a double-blind study. BMJ 1984; 288: 444-6.
43. Picchietti DL, Underwood DJ, Farris WA, Walters AS, Shah MM, Dahl RE et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord 1999; 14: 1000-7.